SHELBY FUGATE: Open Payments
NPI 1891364154 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 41 payments from 7 companies in 2025. Trend: 2023 $544 · 2024 $772 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $203 |
| ABBVIE INC. | 14 | $142 |
| UCB, Inc. | 3 | $61 |
| Janssen Biotech, Inc. | 2 | $37 |
| Organon LLC | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: SKYRIZI, COSENTYX, Bimzelx, RINVOQ, TREMFYA, HADLIMA, Sotyktu, SPEVIGO.
Industry payments across IN — which companies pay providers there.
